{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:32:48Z","timestamp":1784291568855,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent metabolomics studies of Rheumatoid Arthritis (RA) reported few metabolites that were associated with the disease, either due to small cohort sizes or limited coverage of metabolic pathways. Our objective is to identify metabolites associated with RA and its cofounders using a new untargeted metabolomics platform. Moreover, to investigate the pathomechanism of RA by identifying correlations between RA-associated metabolites. 132 RA patients and 104 controls were analyzed for 927 metabolites. Metabolites were tested for association with RA using linear regression. OPLS-DA was used to discriminate RA patients from controls. Gaussian Graphical Models (GGMs) were used to identify correlated metabolites. 32 metabolites are identified as significantly (Bonferroni) associated with RA, including the previously reported metabolites as DHEAS, cortisol and androstenedione and extending that to a larger set of metabolites in the steroid pathway. RA classification using metabolic profiles shows a sensitivity of 91% and specificity of 88%. Steroid levels show variation among the RA patients according to the corticosteroid treatment; lowest in those taking the treatment at the time of the study, higher in those who never took the treatment, and highest in those who took it in the past. Finally, the GGM reflects metabolite relations from the steroidogenesis pathway.<\/jats:p>","DOI":"10.1038\/s41598-017-05439-1","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T14:46:10Z","timestamp":1502894770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Large Scale Metabolic Profiling identifies Novel Steroids linked to Rheumatoid Arthritis"],"prefix":"10.1038","volume":"7","author":[{"given":"Noha A.","family":"Yousri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Bayoumy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wessam Gad","family":"Elhaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Mohney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar Al","family":"Emadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Hammoudeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Halabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Masri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humeira","family":"Badsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad","family":"Uthman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Plenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9638-3912","authenticated-orcid":false,"given":"Karsten","family":"Suhre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2469-0272","authenticated-orcid":false,"given":"Thurayya","family":"Arayssi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"key":"5439_CR1","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/ar3243","volume":"13","author":"RK Madsen","year":"2011","unstructured":"Madsen, R. K. et al. Diagnostic properties of metabolic perturbations in rheumatoid arthritis. Arthritis Res Ther \n                           13, R19 (2011).","journal-title":"Arthritis Res Ther"},{"key":"5439_CR2","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1007\/s00125-015-3636-2","volume":"58","author":"NA Yousri","year":"2015","unstructured":"Yousri, N. A. et al. A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control. Diabetologia \n                           58, 1855\u201367 (2015).","journal-title":"Diabetologia"},{"key":"5439_CR3","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1530\/JOE-14-0024","volume":"221","author":"K Suhre","year":"2014","unstructured":"Suhre, K. Metabolic profiling in diabetes. J Endocrinol \n                           221, R75\u201385 (2014).","journal-title":"J Endocrinol"},{"key":"5439_CR4","doi-asserted-by":"publisher","first-page":"e13953","DOI":"10.1371\/journal.pone.0013953","volume":"5","author":"K Suhre","year":"2010","unstructured":"Suhre, K. et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One \n                           5, e13953 (2010).","journal-title":"PLoS One"},{"key":"5439_CR5","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1021\/pr100101p","volume":"9","author":"JY Kim","year":"2010","unstructured":"Kim, J. Y. et al. Metabolic profiling of plasma in overweight\/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). J Proteome Res \n                           9, 4368\u201375 (2010).","journal-title":"J Proteome Res"},{"key":"5439_CR6","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.jchromb.2011.08.014","volume":"879","author":"C Wang","year":"2011","unstructured":"Wang, C. et al. Metabolic profiling of urine in young obese men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC\/Q-TOF MS). J Chromatogr B Analyt Technol Biomed Life Sci \n                           879, 2871\u20136 (2011).","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"5439_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3945\/an.111.000737","volume":"2","author":"SH Adams","year":"2011","unstructured":"Adams, S. H. Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr \n                           2, 445\u201356 (2011).","journal-title":"Adv Nutr"},{"key":"5439_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.joca.2011.10.010","volume":"20","author":"SB Adams Jr.","year":"2012","unstructured":"Adams, S. B. Jr. et al. Global metabolic profiling of human osteoarthritic synovium. Osteoarthritis Cartilage \n                           20, 64\u20137 (2012).","journal-title":"Osteoarthritis Cartilage"},{"key":"5439_CR9","doi-asserted-by":"publisher","first-page":"e97501","DOI":"10.1371\/journal.pone.0097501","volume":"9","author":"S Kim","year":"2014","unstructured":"Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One \n                           9, e97501 (2014).","journal-title":"PLoS One"},{"key":"5439_CR10","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1021\/pr1002774","volume":"9","author":"MB Lauridsen","year":"2010","unstructured":"Lauridsen, M. B. et al. 1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients. J Proteome Res \n                           9, 4545\u201353 (2010).","journal-title":"J Proteome Res"},{"key":"5439_CR11","doi-asserted-by":"crossref","unstructured":"Volchenkov, R. et al. Metabolic profiling of synovial tissue shows altered glucose and choline metabolism in rheumatoid arthritis samples. Scandinavian Journal of Rheumatology, 1\u20132 (2016).","DOI":"10.3109\/03009742.2016.1164242"},{"key":"5439_CR12","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/art.38021","volume":"65","author":"SP Young","year":"2013","unstructured":"Young, S. P. et al. The impact of inflammation on metabolomic profiles in patients with arthritis. Arthritis Rheum \n                           65, 2015\u201323 (2013).","journal-title":"Arthritis Rheum"},{"key":"5439_CR13","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/nbt1010-1045","volume":"28","author":"BE Bernstein","year":"2010","unstructured":"Bernstein, B. E. et al. The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol \n                           28, 1045\u20131048 (2010).","journal-title":"Nat Biotechnol"},{"key":"5439_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett, F. C. et al. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis & Rheumatism \n                           31, 315\u2013324 (1988).","journal-title":"Arthritis & Rheumatism"},{"key":"5439_CR15","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1002\/art.21946","volume":"54","author":"RH Straub","year":"2006","unstructured":"Straub, R. H., Harle, P., Sarzi-Puttini, P. & Cutolo, M. Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of antiinflammatory action. Arthritis Rheum \n                           54, 2039\u201346 (2006).","journal-title":"Arthritis Rheum"},{"key":"5439_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1749-6632.2002.tb04213.x","volume":"966","author":"M Herrmann","year":"2002","unstructured":"Herrmann, M., Scholmerich, J. & Straub, R. H. Influence of cytokines and growth factors on distinct steroidogenic enzymes in vitro: a short tabular data collection. Ann N Y Acad Sci \n                           966, 166\u201386 (2002).","journal-title":"Ann N Y Acad Sci"},{"key":"5439_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1677\/joe.1.06264","volume":"187","author":"F Labrie","year":"2005","unstructured":"Labrie, F. et al. Is dehydroepiandrosterone a hormone? J Endocrinol \n                           187, 169\u201396 (2005).","journal-title":"J Endocrinol"},{"key":"5439_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/ar2804","volume":"11","author":"M Cutolo","year":"2009","unstructured":"Cutolo, M. Androgens in rheumatoid arthritis: when are they effectors? Arthritis Res Ther \n                           11, 126 (2009).","journal-title":"Arthritis Res Ther"},{"key":"5439_CR19","first-page":"687","volume":"21","author":"M Cutolo","year":"2003","unstructured":"Cutolo, M. et al. New roles for estrogens in rheumatoid arthritis. Clin Exp Rheumatol \n                           21, 687\u201390 (2003).","journal-title":"Clin Exp Rheumatol"},{"key":"5439_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1749-6632.2002.tb04210.x","volume":"966","author":"M Cutolo","year":"2002","unstructured":"Cutolo, M. et al. Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann N Y Acad Sci \n                           966, 131\u201342 (2002).","journal-title":"Ann N Y Acad Sci"},{"key":"5439_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1749-6632.2003.tb03142.x","volume":"992","author":"M Cutolo","year":"2003","unstructured":"Cutolo, M., Sulli, A., Pizzorni, C., Craviotto, C. & Straub, R. H. Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis. Ann N Y Acad Sci \n                           992, 107\u201317 (2003).","journal-title":"Ann N Y Acad Sci"},{"key":"5439_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1210\/edrv.19.2.0326","volume":"19","author":"M Ehrhart-Bornstein","year":"1998","unstructured":"Ehrhart-Bornstein, M., Hinson, J. P., Bornstein, S. R., Scherbaum, W. A. & Vinson, G. P. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev \n                           19, 101\u201343 (1998).","journal-title":"Endocr Rev"},{"key":"5439_CR23","first-page":"1690","volume":"77","author":"G Mastorakos","year":"1993","unstructured":"Mastorakos, G., Chrousos, G. P. & Weber, J. S. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab \n                           77, 1690\u20134 (1993).","journal-title":"J Clin Endocrinol Metab"},{"key":"5439_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.berh.2008.01.010","volume":"22","author":"S Capellino","year":"2008","unstructured":"Capellino, S. & Straub, R. H. Neuroendocrine immune pathways in chronic arthritis. Best Pract Res Clin Rheumatol \n                           22, 285\u201397 (2008).","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5439_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.rdc.2010.09.003","volume":"36","author":"R Imrich","year":"2010","unstructured":"Imrich, R. & Rovensky, J. Hypothalamic-pituitary-adrenal axis in rheumatoid arthritis. Rheum Dis Clin North Am \n                           36, 721\u20137 (2010).","journal-title":"Rheum Dis Clin North Am"},{"key":"5439_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/art.10177","volume":"46","author":"RH Straub","year":"2002","unstructured":"Straub, R. H., Paimela, L., Peltomaa, R., Scholmerich, J. & Leirisalo-Repo, M. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum \n                           46, 654\u201362 (2002).","journal-title":"Arthritis Rheum"},{"key":"5439_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/ard.52.3.211","volume":"52","author":"GM Hall","year":"1993","unstructured":"Hall, G. M., Perry, L. A. & Spector, T. D. Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density. Ann Rheum Dis \n                           52, 211\u20134 (1993).","journal-title":"Ann Rheum Dis"},{"key":"5439_CR28","first-page":"593493","volume":"2013","author":"AT Masi","year":"2013","unstructured":"Masi, A. T. et al. Lower Serum Androstenedione Levels in Pre-Rheumatoid Arthritis versus Normal Control Women: Correlations with Lower Serum Cortisol Levels. Autoimmune Dis \n                           2013, 593493 (2013).","journal-title":"Autoimmune Dis"},{"key":"5439_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1136\/ard.2003.019844","volume":"64","author":"R Imrich","year":"2005","unstructured":"Imrich, R. et al. Low levels of dehydroepiandrosterone sulphate in plasma, and reduced sympathoadrenal response to hypoglycaemia in premenopausal women with rheumatoid arthritis. Ann Rheum Dis \n                           64, 202\u20136 (2005).","journal-title":"Ann Rheum Dis"},{"key":"5439_CR30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1021\/acs.jproteome.5b00951","volume":"15","author":"NA Yousri","year":"2016","unstructured":"Yousri, N. A. et al. Diagnostic and Prognostic Metabolites Identified for Joint Symptoms in the KORA Population. J Proteome Res \n                           15, 554\u201362 (2016).","journal-title":"J Proteome Res"},{"key":"5439_CR31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0889-857X(05)70170-8","volume":"26","author":"KS Kanik","year":"2000","unstructured":"Kanik, K. S. & Wilder, R. L. Hormonal alterations in rheumatoid arthritis, including the effects of pregnancy. Rheum Dis Clin North Am \n                           26, 805\u201323 (2000).","journal-title":"Rheum Dis Clin North Am"},{"key":"5439_CR32","first-page":"1451","volume":"34","author":"S Ernestam","year":"2007","unstructured":"Ernestam, S., Hafstrom, I., Werner, S., Carlstrom, K. & Tengstrand, B. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function. J Rheumatol \n                           34, 1451\u20138 (2007).","journal-title":"J Rheumatol"},{"key":"5439_CR33","doi-asserted-by":"crossref","unstructured":"Shin, S. Y. et al. An atlas of genetic influences on human blood metabolites. Nature Genetics \n                           46, 543\u201350 (2014).","DOI":"10.1038\/ng.2982"},{"key":"5439_CR34","first-page":"161","volume":"34","author":"R Hampl","year":"2000","unstructured":"Hampl, R. & Starka, L. Minireview: 16alpha-hydroxylated metabolites of dehydroepiandrosterone and their biological significance. Endocr Regul \n                           34, 161\u20133 (2000).","journal-title":"Endocr Regul"},{"key":"5439_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jsbmb.2007.03.010","volume":"104","author":"L Zamrazilova","year":"2007","unstructured":"Zamrazilova, L., Kazihnitkova, H., Lapcik, O., Hill, M. & Hampl, R. A novel radioimmunoassay of 16alpha-hydroxy-dehydroepiandrosterone and its physiological levels. J Steroid Biochem Mol Biol \n                           104, 130\u20135 (2007).","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5439_CR36","doi-asserted-by":"publisher","first-page":"R938","DOI":"10.1186\/ar1769","volume":"7","author":"M Schmidt","year":"2005","unstructured":"Schmidt, M. et al. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes\u2013androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens. Arthritis Res Ther \n                           7, R938\u201348 (2005).","journal-title":"Arthritis Res Ther"},{"key":"5439_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.autrev.2003.08.003","volume":"3","author":"M Cutolo","year":"2004","unstructured":"Cutolo, M. et al. Synovial fluid estrogens in rheumatoid arthritis. Autoimmun Rev \n                           3, 193\u20138 (2004).","journal-title":"Autoimmun Rev"},{"key":"5439_CR38","first-page":"2597","volume":"30","author":"LA Castagnetta","year":"2003","unstructured":"Castagnetta, L. A. et al. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol \n                           30, 2597\u2013605 (2003).","journal-title":"J Rheumatol"},{"key":"5439_CR39","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1194\/jlr.R016675","volume":"52","author":"WL Miller","year":"2011","unstructured":"Miller, W. L. & Bose, H. S. Early steps in steroidogenesis: intracellular cholesterol trafficking: Thematic Review Series: Genetics of Human Lipid Diseases. Journal of Lipid Research \n                           52, 2111\u20132135 (2011).","journal-title":"Journal of Lipid Research"},{"key":"5439_CR40","doi-asserted-by":"publisher","first-page":"15954","DOI":"10.1038\/srep15954","volume":"5","author":"N Bordag","year":"2015","unstructured":"Bordag, N. et al. Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects. Sci Rep \n                           5, 15954 (2015).","journal-title":"Sci Rep"},{"key":"5439_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/ijerph7010325","volume":"7","author":"T Faresjo","year":"2010","unstructured":"Faresjo, T. & Faresjo, A. To match or not to match in epidemiological studies\u2013same outcome but less power. Int J Environ Res Public Health \n                           7, 325\u201332 (2010).","journal-title":"Int J Environ Res Public Health"},{"key":"5439_CR42","doi-asserted-by":"publisher","first-page":"c315","DOI":"10.1159\/000323136","volume":"118","author":"MA de Graaf","year":"2011","unstructured":"de Graaf, M. A., Jager, K. J., Zoccali, C. & Dekker, F. W. Matching, an appealing method to avoid confounding? Nephron Clin Pract \n                           118, c315\u20138 (2011).","journal-title":"Nephron Clin Pract"},{"key":"5439_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/osp4.63","volume":"2","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. Metabolomics\u2010identified metabolites associated with body mass index and prospective weight gain among Mexican American women. Obesity Science & Practice \n                           2, 309\u2013317 (2016).","journal-title":"Obesity Science & Practice"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05439-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05439-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05439-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:10:01Z","timestamp":1671786601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05439-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["5439"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-05439-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]},"assertion":[{"value":"16 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.M. is an employee of Metabolon, Inc. and, as such, has affiliations with or financial involvement with Metabolon, Inc. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9137"}}